Docetaxel+Cisplatin+5-FU (DCF) Therapy as a Preoperative Chemotherapy to Advanced Esophageal Squamous Cell Carcinoma: A Single-center Retrospective Cohort Study

OBJECTIVE: The aim of this study was to determine the safety and clinical efficacy of docetaxel+cisplatin+5-fluorouracil (DCF) as neoadjuvant chemotherapy (NAC). METHODS: In this single-center study, patient background and treatment outcomes (NAC efficacy assessment, NAC adverse events, short-term p...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeki, Yusuke, Matsuoka, Hiroshi, Fujita, Masahiro, Goto, Ai, Serizawa, Akiko, Nakamura, Kenichi, Akimoto, Shingo, Nakauchi, Masaya, Tanaka, Tsuyoshi, Shibasaki, Susumu, Inaba, Kazuki, Uyama, Ichiro, Suda, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970804/
https://www.ncbi.nlm.nih.gov/pubmed/36725064
http://dx.doi.org/10.2169/internalmedicine.9751-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970804/
https://www.ncbi.nlm.nih.gov/pubmed/36725064
http://dx.doi.org/10.2169/internalmedicine.9751-22

Ejemplares similares